106 related articles for article (PubMed ID: 11362873)
21. Delavirdine dilemma at the FDA. Food and Drug Administration.
Smart T
GMHC Treat Issues; 1996 Dec; 10(12):4-5. PubMed ID: 11364017
[TBL] [Abstract][Full Text] [Related]
22. AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration.
James JS
AIDS Treat News; 1996 Apr; (no 244):6. PubMed ID: 11363307
[TBL] [Abstract][Full Text] [Related]
23. New FDA rules force drug makers to detail youth-specific effects. Food and Drug Administration.
Newsline People AIDS Coalit N Y; 1999 Jan; ():34. PubMed ID: 11367188
[TBL] [Abstract][Full Text] [Related]
24. Europe learns from US drug mistakes.
Alcorn K
J Int Assoc Physicians AIDS Care; 1996 Mar; 2(3):39. PubMed ID: 11363346
[TBL] [Abstract][Full Text] [Related]
25. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
Mascolini M
AIDS Treat News; 1996 Dec; (No 260):3-5. PubMed ID: 11364022
[TBL] [Abstract][Full Text] [Related]
26. Issues in the design of clinical trials for safety in HIV-infected children.
Lindsey JC; Kline MW
Pediatr AIDS HIV Infect; 1996 Apr; 7(2):69-82. PubMed ID: 11361484
[TBL] [Abstract][Full Text] [Related]
27. FDA notifications. NRTI Emtriva receives FDA approval.
AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301
[TBL] [Abstract][Full Text] [Related]
28. Animal cell transplantation: FDA meeting July 13 and 14. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Jul; (no 226):7-8. PubMed ID: 11362616
[TBL] [Abstract][Full Text] [Related]
29. FDA 'remains committed' to quick approval of AIDS drugs.
Am Pharm; 1994 Dec; NS34(12):14. PubMed ID: 7856502
[No Abstract] [Full Text] [Related]
30. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
Lovell MC
Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
[No Abstract] [Full Text] [Related]
31. Scientific and ethical considerations in trial design for investigational agents for the treatment of human immunodeficiency virus infection.
Feinberg J; Japour AJ
Clin Infect Dis; 2003 Jan; 36(2):201-6. PubMed ID: 12522753
[TBL] [Abstract][Full Text] [Related]
32. Improving drug development: exploratory clinical studies.
James JS
AIDS Treat News; 1999 Jan; (No 310):6. PubMed ID: 11366150
[TBL] [Abstract][Full Text] [Related]
33. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
[No Abstract] [Full Text] [Related]
34. Pemetrexed in malignant pleural mesothelioma.
Hazarika M; White RM; Booth BP; Wang YC; Ham DY; Liang CY; Rahman A; Gobburu JV; Li N; Sridhara R; Morse DE; Lostritto R; Garvey P; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Feb; 11(3):982-92. PubMed ID: 15709163
[TBL] [Abstract][Full Text] [Related]
35. New medicines in development for AIDS: 1994 survey from the Pharmaceutical Research and Manufacturers of America.
Pediatr AIDS HIV Infect; 1995 Apr; 6(2):101-10. PubMed ID: 11361382
[No Abstract] [Full Text] [Related]
36. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
[TBL] [Abstract][Full Text] [Related]
37. Global AIDS trial denied patients as US balks at generic drug use.
Check E
Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
[No Abstract] [Full Text] [Related]
38. Antiviral AIDS drug nears approval.
Science; 1991 Apr; 252(5003):206-7. PubMed ID: 1901425
[No Abstract] [Full Text] [Related]
39. Therapies. Confronting the limits of success.
Cohen J
Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
[No Abstract] [Full Text] [Related]
40. Protease inhibitor update: treatment combination strategies.
Mascolini M
AIDS Treat News; 1996 Jan; (no 239):3. PubMed ID: 11363085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
